| Use of transgenic animals in biotechnology: prospects and problems OG Maksimenko, AV Deykin, PG Georgiev Acta Naturae (англоязычная версия) 5 (1 (16)), 33-46, 2013 | 166* | 2013 |
| Fused in Sarcoma (FUS) Protein Lacking Nuclear Localization Signal (NLS) and Major RNA Binding Motifs Triggers Proteinopathy and Severe Motor Phenotype in Transgenic Mice*♦ TA Shelkovnikova, OM Peters, AV Deykin, N Connor-Robson, ... Journal of biological chemistry 288 (35), 25266-25274, 2013 | 143 | 2013 |
| Генетические маркеры в мясном овцеводстве АВ Дейкин, МИ Селионова, АЮ Криворучко, ДВ Коваленко, ... Вавиловский журнал генетики и селекции 20 (5), 576-583, 2016 | 91* | 2016 |
| Stem cells in human breast milk N Ninkina, MS Kukharsky, MV Hewitt, EA Lysikova, LN Skuratovska, ... Human Cell 32, 223-230, 2019 | 79 | 2019 |
| Production of human lactoferrin in animal milk IL Goldman, SG Georgieva, YG Gurskiy, AN Krasnov, AV Deykin, ... Biochemistry and Cell Biology 90 (3), 513-519, 2012 | 71* | 2012 |
| Получение рекомбинантных белков из молока трансгенных животных: современное состояние и перспективы МВ Шепелев, СВ Калиниченко, АВ Дейкин, ИВ Коробко Acta Naturae (русскоязычная версия) 10 (3 (38)), 42-50, 2018 | 48* | 2018 |
| CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene TV Egorova, ED Zotova, DA Reshetov, AV Polikarpova, SG Vassilieva, ... Disease Models & Mechanisms 12 (4), dmm037655, 2019 | 42 | 2019 |
| Animal models of human atherosclerosis: current progress AV Poznyak, YY Silaeva, AN Orekhov, AV Deykin Brazilian Journal of Medical and Biological Research 53, e9557, 2020 | 35 | 2020 |
| Модель бокового амиотрофического склероза на основе линии трансгенных мышей, экспрессирующих мутантную форму FUS белка человека АВ ДЕЙКИН, ЕА КОВРАЖКИНА, РК ОВЧИННИКОВ, ... Журнал неврологии и психиатрии им. С.С. Корсакова 114 (8), 62-69, 2014 | 31* | 2014 |
| On the way from SARS-CoV-sensitive mice to murine COVID-19 model VO Soldatov, MV Kubekina, YY Silaeva, AV Bruter, AV Deykin Research Results in Pharmacology 6 (2), 1-7, 2020 | 29 | 2020 |
| Cytokines in abdominal aortic aneurysm: master regulators with clinical application OA Puchenkova, VO Soldatov, AE Belykh, OY Bushueva, GA Piavchenko, ... Biomarker Insights 17, 11772719221095676, 2022 | 27 | 2022 |
| Decrease in pool of T lymphocytes with surface phenotypes of effector and central memory cells under influence of TCR transgenic β-chain expression YY Silaeva, AA Kalinina, MS Vagida, LM Khromykh, AV Deikin, ... Biochemistry (Moscow) 78, 549-559, 2013 | 27* | 2013 |
| Early lethality and neuronal proteinopathy in mice expressing cytoplasm-targeted FUS that lacks the RNA recognition motif HK Robinson, AV Deykin, EV Bronovitsky, RK Ovchinnikov, AA Ustyugov, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (5-6), 402-409, 2015 | 26 | 2015 |
| Modelling of atherosclerosis in genetically modified animals NV Mushenkova, VI Summerhill, YY Silaeva, AV Deykin, AN Orekhov American journal of translational research 11 (8), 4614, 2019 | 23 | 2019 |
| The development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice YG Gurskiy, DG Garbuz, NV Soshnikova, AN Krasnov, A Deikin, ... Cell Stress and Chaperones 21, 1055-1064, 2016 | 23 | 2016 |
| An update on the tools for creating transgenic animal models of human diseases–focus on atherosclerosis AS Volobueva, AN Orekhov, AV Deykin Brazilian Journal of Medical and Biological Research 52, e8108, 2019 | 21 | 2019 |
| Generation of transgenic animals expressing the α and β chains of the autoreactive T-cell receptor ES Zvezdova, YY Silaeva, MS Vagida, EV Maryukhnich, AV Deikin, ... Molecular biology 44, 277-286, 2010 | 20* | 2010 |
| Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis AV Bruter, DS Korshunova, MV Kubekina, PV Sergiev, AA Kalinina, ... Transgenic research 30, 289-301, 2021 | 18* | 2021 |
| Retinal damage in amyotrophic lateral sclerosis: Underlying mechanisms VO Soldatov, MS Kukharsky, AE Belykh, AM Sobolev, AV Deykin Eye and Brain, 131-146, 2021 | 18 | 2021 |
| Перспективы использования гамма-карболинов для разработки патогенетической терапии протеинопатий ВИ Скворцова, СО Бачурин, АА Устюгов, МС Кухарский, АВ Дейкин, ... Acta Naturae (русскоязычная версия) 10 (4 (39)), 59-62, 2018 | 17* | 2018 |
Aleksey UstyugovDirector, Institute of Physiologically Active Compounds at Federal Research Center of Problems ofVerified email at ipac.ac.ru
